Langer, G.A.: Ionic movements and the control of contraction, in The Mammalian Myocardium . New York, John Wiley and Sons , 1974, pp. 193-217.
2.
Nayler, W.G. , Krikler, D.: Verapamil and the myocardium. Postgrad. Med. J., 50: 441, 1974.
3.
Anderson, K.E. : Effects of calcium and calcium antagonists on the excitation-contraction coupling in striated and smooth muscle. Acta Pharmacol. Toxicol., 43 (Suppl. 1): 5, 1978.
4.
Fleckenstein, A.: Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol., 17: 149, 1977.
5.
Godfraind, T., Morel, E.: Inhibitors of calcium influx, in Mechanisms of Vasodilatation. Satellite Symp., 27th Int. Congr. Physiol. Sci, Wilrijk1977. Basel, Karger , 1978, pp. 144-151.
Gillespie, J.A. : The case against vasodilator drugs in occlusive vascular disease of the legs. Lancet, 2: 995, 1959.
8.
Rhawan, R.G. , Piascik, M.F., Witiak, D.T.: The role of calcium antagonism in the therapeutic action of drugs. Can. J. Physiol. Pharmacol., 57: 443, 1979.
9.
Van Nueten, J.M., Wellens, D.: Mechanism of vasodilatation and antivasoconstriction . Angiology, 30: 440, 1979.
10.
Van Nueten, J.M., Tobia, A.J., McGuire, J.L.: Antagonism of vascular smooth muscle contraction by flunarizine. Fed. Proc. Fed. Am. Soc. Exp. Biol., 37: 793, 1978.
11.
Godfraind, T., Kaba, A.: The role of calcium in the action of drugs on vascular smooth muscle. Arch. Int. Pharmacodyn. Ther., 196: 35, 1972.
12.
Bohr, D.F., Greenberg, S. and Bonaccorsi, A.: Mechanisms of action of vasoactive agents, in Microcirculation. Edited by G. Kaley and B. M. Altura. New York, Academic Press, 1978, pp. 311-348.
13.
Shepherd, J.T. , Vanhoutte, P.M.: The Human Cardiovascular System. Facts and Concepts. New York, Raven Press , 1979.
14.
Verhaegen, H., Roels, V., Adriaensen, H., et al.: The arteriolar effects of cinnarizine and flunarizine. Angiology, 25: 261, 1974.
15.
Verhaegen, H., Reyntjens, A., Hörig, C., et al.: Responsiveness of various symptoms of vascular disorders to calcium antagonists. Angiology, 30: 447, 1979.
16.
Weed, R.R., La Celle, P.L., Merrill, E.W.: Metabolic dependence of red cell deformability. J. Clin. Invest. , 48: 795, 1969.
17.
Anderson, D.R. , Davis, J.L., Carraway, K.L.: Calcium-promoted changes of the human erythrocyte membrane. J. Biol. Chem., 252: 6617, 1977.
18.
Marcel, G.A. : Red cell deformability: physiological, clinical and pharmacological aspects. J. Med., 10: 409, 1979.
19.
Reid, H.L., Dormandy, J.A., Barnes, A.J., et al.: Impaired red cell deformability in peripheral vascular disease . Lancet, 4: 666, 1976.
20.
De Cree, J. , De Cock, W., Geukens, H., et al.: The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology , 30: 505, 1979.
21.
Scott, C., Chasin, M.: Effects of flunarizine on red blood cells. Pharmacologist , 20: 204, 1978.
22.
Di Perri, T. , Forconi, S., Guerini, M., et al.: Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Proc. R. Soc. Med., 70 (Suppl. 8): 25, 1977.
23.
Flameng, W. , Verheyen, F., Borgers, M., et al.: The effect of flunarizine treatment of human red blood cells. Angiology, 30: 516, 1979.
24.
Jaspersen, J., Waldmann, S.: Die Wirkung von Sibelium auf die arterielle und venöse Beindurchblutung bei Patienten mit geringer Belastbarkeit. Therapiewoche, 7: 6331, 1977.
25.
Roekaerts, F. , Vanden Bussche, G.: Double-blind, placebo-controlled studies with flunarizine in venous insufficiency. Presented at the XXIInd Annual Meeting of the International College of Angiology, Vienna, 1980.
26.
Van Nueten, J.M. , Vanhoutte, P.M.: Improvement of tissue perfusion with inhibitors of calcium ion influx. Biochem. Pharmacol., 29: 479, 1980.
27.
Jageneau, A., Loots, W., Brugmans, J.: Prolongation of anoxia-induced hyperemia in healthy middle-aged men treated with cinnarizine and flunarizine. Drug Res., 24: 1839, 1974.
28.
Nihard, P.: The effect of calcium antagonists on arterioles, capillaries and venules of the retina. Presented at the XXIInd Annual Meeting of the International College of Angiology, Vienna, 1980.
29.
De Clerck, F., Beerens, M., Thoné, F., et al.: The effect of flunarizine and other vasoactive compounds on the human RBCcrenation and on the calcium deposition induced by ionophore A23187. Biorheology, 16: 522, 1979.
30.
Heykants, J. , De Crée, J., Hörig, C.: Steady-state plasma levels of flunarizine in chronically treated patients. Drug Res., 29: 1168, 1979.